Literature DB >> 28854165

Cancer models: The next best thing.

Mark A Murakami1, David M Weinstock1,2.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28854165     DOI: 10.1038/nature23545

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  8 in total

1.  Declining childhood and adolescent cancer mortality.

Authors:  Malcolm A Smith; Sean F Altekruse; Peter C Adamson; Gregory H Reaman; Nita L Seibel
Journal:  Cancer       Date:  2014-05-22       Impact factor: 6.860

Review 2.  Examining the utility of patient-derived xenograft mouse models.

Authors:  Samuel Aparicio; Manuel Hidalgo; Andrew L Kung
Journal:  Nat Rev Cancer       Date:  2015-05       Impact factor: 60.716

3.  High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response.

Authors:  Hui Gao; Joshua M Korn; Stéphane Ferretti; John E Monahan; Youzhen Wang; Mallika Singh; Chao Zhang; Christian Schnell; Guizhi Yang; Yun Zhang; O Alejandro Balbin; Stéphanie Barbe; Hongbo Cai; Fergal Casey; Susmita Chatterjee; Derek Y Chiang; Shannon Chuai; Shawn M Cogan; Scott D Collins; Ernesta Dammassa; Nicolas Ebel; Millicent Embry; John Green; Audrey Kauffmann; Colleen Kowal; Rebecca J Leary; Joseph Lehar; Ying Liang; Alice Loo; Edward Lorenzana; E Robert McDonald; Margaret E McLaughlin; Jason Merkin; Ronald Meyer; Tara L Naylor; Montesa Patawaran; Anupama Reddy; Claudia Röelli; David A Ruddy; Fernando Salangsang; Francesca Santacroce; Angad P Singh; Yan Tang; Walter Tinetto; Sonja Tobler; Roberto Velazquez; Kavitha Venkatesan; Fabian Von Arx; Hui Qin Wang; Zongyao Wang; Marion Wiesmann; Daniel Wyss; Fiona Xu; Hans Bitter; Peter Atadja; Emma Lees; Francesco Hofmann; En Li; Nicholas Keen; Robert Cozens; Michael Rugaard Jensen; Nancy K Pryer; Juliet A Williams; William R Sellers
Journal:  Nat Med       Date:  2015-10-19       Impact factor: 53.440

4.  Functional heterogeneity of genetically defined subclones in acute myeloid leukemia.

Authors:  Jeffery M Klco; David H Spencer; Christopher A Miller; Malachi Griffith; Tamara L Lamprecht; Michelle O'Laughlin; Catrina Fronick; Vincent Magrini; Ryan T Demeter; Robert S Fulton; William C Eades; Daniel C Link; Timothy A Graubert; Matthew J Walter; Elaine R Mardis; John F Dipersio; Richard K Wilson; Timothy J Ley
Journal:  Cancer Cell       Date:  2014-03-06       Impact factor: 31.743

Review 5.  Interrogating open issues in cancer precision medicine with patient-derived xenografts.

Authors:  Annette T Byrne; Denis G Alférez; Frédéric Amant; Daniela Annibali; Joaquín Arribas; Andrew V Biankin; Alejandra Bruna; Eva Budinská; Carlos Caldas; David K Chang; Robert B Clarke; Hans Clevers; George Coukos; Virginie Dangles-Marie; S Gail Eckhardt; Eva Gonzalez-Suarez; Els Hermans; Manuel Hidalgo; Monika A Jarzabek; Steven de Jong; Jos Jonkers; Kristel Kemper; Luisa Lanfrancone; Gunhild Mari Mælandsmo; Elisabetta Marangoni; Jean-Christophe Marine; Enzo Medico; Jens Henrik Norum; Héctor G Palmer; Daniel S Peeper; Pier Giuseppe Pelicci; Alejandro Piris-Gimenez; Sergio Roman-Roman; Oscar M Rueda; Joan Seoane; Violeta Serra; Laura Soucek; Dominique Vanhecke; Alberto Villanueva; Emilie Vinolo; Andrea Bertotti; Livio Trusolino
Journal:  Nat Rev Cancer       Date:  2017-01-20       Impact factor: 60.716

6.  Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells.

Authors:  Leonard D Shultz; Bonnie L Lyons; Lisa M Burzenski; Bruce Gott; Xiaohua Chen; Stanley Chaleff; Malak Kotb; Stephen D Gillies; Marie King; Julie Mangada; Dale L Greiner; Rupert Handgretinger
Journal:  J Immunol       Date:  2005-05-15       Impact factor: 5.422

7.  The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice.

Authors:  Elizabeth C Townsend; Mark A Murakami; Alexandra Christodoulou; Amanda L Christie; Johannes Köster; Tiffany A DeSouza; Elizabeth A Morgan; Scott P Kallgren; Huiyun Liu; Shuo-Chieh Wu; Olivia Plana; Joan Montero; Kristen E Stevenson; Prakash Rao; Raga Vadhi; Michael Andreeff; Philippe Armand; Karen K Ballen; Patrizia Barzaghi-Rinaudo; Sarah Cahill; Rachael A Clark; Vesselina G Cooke; Matthew S Davids; Daniel J DeAngelo; David M Dorfman; Hilary Eaton; Benjamin L Ebert; Julia Etchin; Brant Firestone; David C Fisher; Arnold S Freedman; Ilene A Galinsky; Hui Gao; Jacqueline S Garcia; Francine Garnache-Ottou; Timothy A Graubert; Alejandro Gutierrez; Ensar Halilovic; Marian H Harris; Zachary T Herbert; Steven M Horwitz; Giorgio Inghirami; Andrew M Intlekofer; Moriko Ito; Shai Izraeli; Eric D Jacobsen; Caron A Jacobson; Sébastien Jeay; Irmela Jeremias; Michelle A Kelliher; Raphael Koch; Marina Konopleva; Nadja Kopp; Steven M Kornblau; Andrew L Kung; Thomas S Kupper; Nicole R LeBoeuf; Ann S LaCasce; Emma Lees; Loretta S Li; A Thomas Look; Masato Murakami; Markus Muschen; Donna Neuberg; Samuel Y Ng; Oreofe O Odejide; Stuart H Orkin; Rachel R Paquette; Andrew E Place; Justine E Roderick; Jeremy A Ryan; Stephen E Sallan; Brent Shoji; Lewis B Silverman; Robert J Soiffer; David P Steensma; Kimberly Stegmaier; Richard M Stone; Jerome Tamburini; Aaron R Thorner; Paul van Hummelen; Martha Wadleigh; Marion Wiesmann; Andrew P Weng; Jens U Wuerthner; David A Williams; Bruce M Wollison; Andrew A Lane; Anthony Letai; Monica M Bertagnolli; Jerome Ritz; Myles Brown; Henry Long; Jon C Aster; Margaret A Shipp; James D Griffin; David M Weinstock
Journal:  Cancer Cell       Date:  2016-04-11       Impact factor: 31.743

8.  Orthotopic patient-derived xenografts of paediatric solid tumours.

Authors:  Elizabeth Stewart; Sara M Federico; Xiang Chen; Anang A Shelat; Cori Bradley; Brittney Gordon; Asa Karlstrom; Nathaniel R Twarog; Michael R Clay; Armita Bahrami; Burgess B Freeman; Beisi Xu; Xin Zhou; Jianrong Wu; Victoria Honnell; Monica Ocarz; Kaley Blankenship; Jason Dapper; Elaine R Mardis; Richard K Wilson; James Downing; Jinghui Zhang; John Easton; Alberto Pappo; Michael A Dyer
Journal:  Nature       Date:  2017-08-30       Impact factor: 49.962

  8 in total
  2 in total

1.  CORR Insights®: Micrometastatic Drug Screening Platform Shows Heterogeneous Response to MAP Chemotherapy in Osteosarcoma Cell Lines.

Authors:  Bruno Fuchs
Journal:  Clin Orthop Relat Res       Date:  2018-07       Impact factor: 4.176

Review 2.  Using PDX for Preclinical Cancer Drug Discovery: The Evolving Field.

Authors:  Juliet A Williams
Journal:  J Clin Med       Date:  2018-03-02       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.